Covered recipient · General Payments record
SIMONE L FISH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,137.12
- Reported across 184 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $504.06 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $175.08 | 2 |
| Acerta Pharma LLC | $108.34 | 3 |
| Novo Nordisk AS | $85.50 | 5 |
| PFIZER INC. | $37.84 | 2 |
| ABBVIE INC. | $34.86 | 2 |
| Merck Sharp & Dohme Corporation | $29.18 | 1 |
| Amgen Inc. | $18.35 | 1 |
| Dynavax Technologies Corporation | $14.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.19 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125345927 | CMS |
| Abbott Laboratories | $153.89 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125345929 | CMS |
| ABBVIE INC. | $16.12 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381359 | CMS |
| ABBVIE INC. | $18.74 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381361 | CMS |
| Amgen Inc. | $18.35 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117515659 | CMS |
| AstraZeneca Pharmaceuticals LP | $77.25 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105736425 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.05 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105558128 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.04 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104275389 | CMS |
| Dynavax Technologies Corporation | $14.91 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082147375 | CMS |
| Merck Sharp & Dohme LLC | $29.18 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141973045 | CMS |
| Novo Nordisk Inc | $13.16 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096697596 | CMS |
| Novo Nordisk Inc | $15.42 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096714165 | CMS |
| Novo Nordisk Inc | $18.79 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096735607 | CMS |
| Novo Nordisk Inc | $19.35 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096913570 | CMS |
| Novo Nordisk Inc | $18.78 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096964622 | CMS |
| PFIZER INC. | $17.71 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131722994 | CMS |
| PFIZER INC. | $20.13 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131772513 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.